Patents by Inventor Srinivas Chakra Chennubhotla

Srinivas Chakra Chennubhotla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11842488
    Abstract: Pathologists are adopting digital pathology for diagnosis, using whole slide images (WSIs). Explainable AI (xAI) is a new approach to AI that can reveal underlying reasons for its results. As such, xAI can promote safety, reliability, and accountability of machine learning for critical tasks such as pathology diagnosis. HistoMapr provides intelligent xAI guides for pathologists to improve the efficiency and accuracy of pathological diagnoses. HistoMapr can previews entire pathology cases' WSIs, identifies key diagnostic regions of interest (ROIs), determines one or more conditions associated with each ROI, provisionally labels each ROI with the identified conditions, and can triages them. The ROIs are presented to the pathologist in an interactive, explainable fashion for rapid interpretation. The pathologist can be in control and can access xAI analysis via a “why?” interface. HistoMapr can track the pathologist's decisions and assemble a pathology report using suggested, standardized terminology.
    Type: Grant
    Filed: June 17, 2022
    Date of Patent: December 12, 2023
    Assignee: SpIntellx, Inc.
    Inventors: Akif Burak Tosun, Srinivas Chakra Chennubhotla, Jeffrey Louis Fine
  • Publication number: 20230142758
    Abstract: Pathologists are adopting digital pathology for diagnosis, using whole slide images (WSIs). Explainable AI (xAI) is a new approach to AI that can reveal underlying reasons for its results. As such, xAI can promote safety, reliability, and accountability of machine learning for critical tasks such as pathology diagnosis. HistoMapr provides intelligent xAI guides for pathologists to improve the efficiency and accuracy of pathological diagnoses. HistoMapr can previews entire pathology cases' WSIs, identifies key diagnostic regions of interest (ROls), determines one or more conditions associated with each ROI, provisionally labels each ROI with the identified conditions, and can triages them. The ROls are presented to the pathologist in an interactive, explainable fashion for rapid interpretation. The pathologist can be in control and can access xAI analysis via a “why?” interface. HistoMapr can track the pathologist's decisions and assemble a pathology report using suggested, standardized terminology.
    Type: Application
    Filed: June 17, 2022
    Publication date: May 11, 2023
    Inventors: Akif Burak Tosun, Srinivas Chakra Chennubhotla, Jeffrey Louis Fine
  • Patent number: 11367184
    Abstract: Pathologists are adopting digital pathology for diagnosis, using whole slide images (WSIs). Explainable AI (xAI) is a new approach to AI that can reveal underlying reasons for its results. As such, xAI can promote safety, reliability, and accountability of machine learning for critical tasks such as pathology diagnosis. HistoMapr provides intelligent xAI guides for pathologists to improve the efficiency and accuracy of pathological diagnoses. HistoMapr can previews entire pathology cases' WSIs, identifies key diagnostic regions of interest (ROIs), determines one or more conditions associated with each ROI, provisionally labels each ROI with the identified conditions, and can triages them. The ROIs are presented to the pathologist in an interactive, explainable fashion for rapid interpretation. The pathologist can be in control and can access xAI analysis via a “why?” interface. HistoMapr can track the pathologist's decisions and assemble a pathology report using suggested, standardized terminology.
    Type: Grant
    Filed: March 16, 2020
    Date of Patent: June 21, 2022
    Assignee: SPINTELLX, INC.
    Inventors: Akif Burak Tosun, Srinivas Chakra Chennubhotla, Jeffrey Louis Fine
  • Publication number: 20200294231
    Abstract: Pathologists are adopting digital pathology for diagnosis, using whole slide images (WSIs). Explainable AI (xAI) is a new approach to AI that can reveal underlying reasons for its results. As such, xAI can promote safety, reliability, and accountability of machine learning for critical tasks such as pathology diagnosis. HistoMapr provides intelligent xAI guides for pathologists to improve the efficiency and accuracy of pathological diagnoses. HistoMapr can previews entire pathology cases' WSIs, identifies key diagnostic regions of interest (ROIs), determines one or more conditions associated with each ROI, provisionally labels each ROI with the identified conditions, and can triages them. The ROIs are presented to the pathologist in an interactive, explainable fashion for rapid interpretation. The pathologist can be in control and can access xAI analysis via a “why?” interface. HistoMapr can track the pathologist's decisions and assemble a pathology report using suggested, standardized terminology.
    Type: Application
    Filed: March 16, 2020
    Publication date: September 17, 2020
    Inventors: Akif Burak Tosun, Srinivas Chakra Chennubhotla, Jeffrey Louis Fine